APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liposome Development and Manufacturing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Liposome Development and Manufacturing Service Market Outlook and Growth Opportunities 2026

10 April 2026Not stated

Choose your research edition.

Industry ResearchLiposome Development and Manufacturing Service Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Liposome Development and Manufacturing Service Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Liposome Development and Manufacturing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liposome Development and Manufacturing Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Liposome Development and Manufacturing Service Market Analysis and Forecast 2026-2032235 pages · $4,950 USD

Market perspective

The global Liposome Development and Manufacturing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Liposome Development and Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Liposome Development and Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Liposome Development and Manufacturing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Liposome Development and Manufacturing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Liposome Development and Manufacturing Service market include Baxter BioPharma Solutions, Charles River Laboratories, Evonik, Fresenius Kabi, Fujifilm, GEA and Intertek, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Liposome Development and Manufacturing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Liposome Development and Manufacturing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Liposome Development and Manufacturing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Liposome Development and Manufacturing Service market.

Liposome Development and Manufacturing Service Segment by Company

Baxter BioPharma Solutions

Charles River Laboratories

Evonik

Fresenius Kabi

Fujifilm

GEA

Intertek

Liposome Development and Manufacturing Service Segment by Type

Thaw Type

Freeze-dried

Liposome Development and Manufacturing Service Segment by Application

Cosmetic

Agriculture

Food

The Medical

Other

Liposome Development and Manufacturing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Liposome Development and Manufacturing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Liposome Development and Manufacturing Service key companies, revenue, market share, and recent developments.

3. To split the Liposome Development and Manufacturing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Liposome Development and Manufacturing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Liposome Development and Manufacturing Service significant trends, drivers, influence factors in global and regions.

6. To analyze Liposome Development and Manufacturing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liposome Development and Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liposome Development and Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liposome Development and Manufacturing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Liposome Development and Manufacturing Service industry.

Chapter 3: Detailed analysis of Liposome Development and Manufacturing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Liposome Development and Manufacturing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Liposome Development and Manufacturing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Liposome Development and Manufacturing Service Industry Trends Table 2. Liposome Development and Manufacturing Service Industry Drivers Table 3. Liposome Development and Manufacturing Service Industry Opportunities and Challenges Table 4. Liposome Development and Manufacturing Service Industry Restraints Table 5. Global Liposome Development and Manufacturing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Liposome Development and Manufacturing Service Revenue Share by Company (2021-2026) Table 7. Global Liposome Development and Manufacturing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Liposome Development and Manufacturing Service Key Company Manufacturing Base & Headquarters Table 9. Global Liposome Development and Manufacturing Service Company, Product Type & Application Table 10. Global Liposome Development and Manufacturing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Liposome Development and Manufacturing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Thaw Type Table 15. Significant Companies of Freeze-dried Table 16. Global Liposome Development and Manufacturing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Liposome Development and Manufacturing Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Liposome Development and Manufacturing Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Liposome Development and Manufacturing Service Sales Value Share by Type (2021-2026) Table 20. Global Liposome Development and Manufacturing Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Cosmetic Table 22. Significant Companies of Agriculture Table 23. Significant Companies of Food Table 24. Significant Companies of The Medical Table 25. Significant Companies of Other Table 26. Global Liposome Development and Manufacturing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Liposome Development and Manufacturing Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Liposome Development and Manufacturing Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Liposome Development and Manufacturing Service Sales Value Share by Application (2021-2026) Table 30. Global Liposome Development and Manufacturing Service Sales Value Share by Application (2027-2032) Table 31. Global Liposome Development and Manufacturing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Liposome Development and Manufacturing Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Liposome Development and Manufacturing Service Sales Value Share by Region (2021-2026) Table 34. Global Liposome Development and Manufacturing Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Liposome Development and Manufacturing Service Sales Value Share by Region (2027-2032) Table 36. Global Liposome Development and Manufacturing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Liposome Development and Manufacturing Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Liposome Development and Manufacturing Service Sales Value Market Share by Country (2021-2026) Table 39. Global Liposome Development and Manufacturing Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Liposome Development and Manufacturing Service Sales Value Market Share by Country (2027-2032) Table 41. Baxter BioPharma Solutions Company Information Table 42. Baxter BioPharma Solutions Business Overview Table 43. Baxter BioPharma Solutions Liposome Development and Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Baxter BioPharma Solutions Liposome Development and Manufacturing Service Product Portfolio Table 45. Baxter BioPharma Solutions Recent Development Table 46. Charles River Laboratories Company Information Table 47. Charles River Laboratories Business Overview Table 48. Charles River Laboratories Liposome Development and Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Charles River Laboratories Liposome Development and Manufacturing Service Product Portfolio Table 50. Charles River Laboratories Recent Development Table 51. Evonik Company Information Table 52. Evonik Business Overview Table 53. Evonik Liposome Development and Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Evonik Liposome Development and Manufacturing Service Product Portfolio Table 55. Evonik Recent Development Table 56. Fresenius Kabi Company Information Table 57. Fresenius Kabi Business Overview Table 58. Fresenius Kabi Liposome Development and Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Fresenius Kabi Liposome Development and Manufacturing Service Product Portfolio Table 60. Fresenius Kabi Recent Development Table 61. Fujifilm Company Information Table 62. Fujifilm Business Overview Table 63. Fujifilm Liposome Development and Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Fujifilm Liposome Development and Manufacturing Service Product Portfolio Table 65. Fujifilm Recent Development Table 66. GEA Company Information Table 67. GEA Business Overview Table 68. GEA Liposome Development and Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. GEA Liposome Development and Manufacturing Service Product Portfolio Table 70. GEA Recent Development Table 71. Intertek Company Information Table 72. Intertek Business Overview Table 73. Intertek Liposome Development and Manufacturing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Intertek Liposome Development and Manufacturing Service Product Portfolio Table 75. Intertek Recent Development Table 76. Research Programs/Design for This Report Table 77. Authors List of This Report Table 78. Secondary Sources Table 79. Primary Sources List of Figures Figure 1. Liposome Development and Manufacturing Service Product Image Figure 2. Global Liposome Development and Manufacturing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liposome Development and Manufacturing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Liposome Development and Manufacturing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Thaw Type Image Figure 8. Freeze-dried Image Figure 9. Global Liposome Development and Manufacturing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Liposome Development and Manufacturing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Liposome Development and Manufacturing Service Sales Value Share by Type (2021-2032) Figure 12. Cosmetic Image Figure 13. Agriculture Image Figure 14. Food Image Figure 15. The Medical Image Figure 16. Other Image Figure 17. Global Liposome Development and Manufacturing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Liposome Development and Manufacturing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Liposome Development and Manufacturing Service Sales Value Share by Application (2021-2032) Figure 20. Global Liposome Development and Manufacturing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Liposome Development and Manufacturing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Liposome Development and Manufacturing Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America Liposome Development and Manufacturing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Liposome Development and Manufacturing Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Liposome Development and Manufacturing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Liposome Development and Manufacturing Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Liposome Development and Manufacturing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Liposome Development and Manufacturing Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America Liposome Development and Manufacturing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Liposome Development and Manufacturing Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Liposome Development and Manufacturing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Thaw Type
  • Freeze-dried
Applications
  • Cosmetic
  • Agriculture
  • Food
  • The Medical
  • Other
Companies covered
  • Baxter BioPharma Solutions
  • Charles River Laboratories
  • Evonik
  • Fresenius Kabi
  • Fujifilm
  • GEA
  • Intertek

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Liposome Development and Manufacturing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Liposome Development and Manufacturing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Liposome Development and Manufacturing Service Market Dynamics
  1. 2.1 Liposome Development and Manufacturing Service Industry Trends
  2. 2.2 Liposome Development and Manufacturing Service Industry Drivers
  3. 2.3 Liposome Development and Manufacturing Service Industry Opportunities and Challenges
  4. 2.4 Liposome Development and Manufacturing Service Industry Restraints
3 Liposome Development and Manufacturing Service Market by Company
  1. 3.1 Global Liposome Development and Manufacturing Service Company Revenue Ranking in 2025
  2. 3.2 Global Liposome Development and Manufacturing Service Revenue by Company (2021-2026)
  3. 3.3 Global Liposome Development and Manufacturing Service Company Ranking (2024-2026)
  4. 3.4 Global Liposome Development and Manufacturing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Liposome Development and Manufacturing Service Company Product Type and Application
  6. 3.6 Global Liposome Development and Manufacturing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Liposome Development and Manufacturing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Liposome Development and Manufacturing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Liposome Development and Manufacturing Service Market by Type
  1. 4.1 Liposome Development and Manufacturing Service Type Introduction
  2. 4.1.1 Thaw Type
  3. 4.1.2 Freeze-dried
  4. 4.2 Global Liposome Development and Manufacturing Service Sales Value by Type
  5. 4.2.1 Global Liposome Development and Manufacturing Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Liposome Development and Manufacturing Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Liposome Development and Manufacturing Service Sales Value Share by Type (2021-2032)
5 Liposome Development and Manufacturing Service Market by Application
  1. 5.1 Liposome Development and Manufacturing Service Application Introduction
  2. 5.1.1 Cosmetic
  3. 5.1.2 Agriculture
  4. 5.1.3 Food
  5. 5.1.4 The Medical
  6. 5.1.5 Other
  7. 5.2 Global Liposome Development and Manufacturing Service Sales Value by Application
  8. 5.2.1 Global Liposome Development and Manufacturing Service Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Liposome Development and Manufacturing Service Sales Value by Application (2021-2032)
  10. 5.2.3 Global Liposome Development and Manufacturing Service Sales Value Share by Application (2021-2032)
6 Liposome Development and Manufacturing Service Regional Value Analysis
  1. 6.1 Global Liposome Development and Manufacturing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Liposome Development and Manufacturing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Liposome Development and Manufacturing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Liposome Development and Manufacturing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Liposome Development and Manufacturing Service Sales Value (2021-2032)
  7. 6.3.2 North America Liposome Development and Manufacturing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Liposome Development and Manufacturing Service Sales Value (2021-2032)
  10. 6.4.2 Europe Liposome Development and Manufacturing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Liposome Development and Manufacturing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Liposome Development and Manufacturing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Liposome Development and Manufacturing Service Sales Value (2021-2032)
  16. 6.6.2 South America Liposome Development and Manufacturing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Liposome Development and Manufacturing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Liposome Development and Manufacturing Service Sales Value Share by Country, 2025 VS 2032
7 Liposome Development and Manufacturing Service Country-level Value Analysis
  1. 7.1 Global Liposome Development and Manufacturing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Liposome Development and Manufacturing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Liposome Development and Manufacturing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Liposome Development and Manufacturing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Liposome Development and Manufacturing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Liposome Development and Manufacturing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Liposome Development and Manufacturing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Baxter BioPharma Solutions
  2. 8.1.1 Baxter BioPharma Solutions Company Information
  3. 8.1.2 Baxter BioPharma Solutions Business Overview
  4. 8.1.3 Baxter BioPharma Solutions Liposome Development and Manufacturing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Baxter BioPharma Solutions Liposome Development and Manufacturing Service Product Portfolio
  6. 8.1.5 Baxter BioPharma Solutions Recent Developments
  7. 8.2 Charles River Laboratories
  8. 8.2.1 Charles River Laboratories Company Information
  9. 8.2.2 Charles River Laboratories Business Overview
  10. 8.2.3 Charles River Laboratories Liposome Development and Manufacturing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Charles River Laboratories Liposome Development and Manufacturing Service Product Portfolio
  12. 8.2.5 Charles River Laboratories Recent Developments
  13. 8.3 Evonik
  14. 8.3.1 Evonik Company Information
  15. 8.3.2 Evonik Business Overview
  16. 8.3.3 Evonik Liposome Development and Manufacturing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Evonik Liposome Development and Manufacturing Service Product Portfolio
  18. 8.3.5 Evonik Recent Developments
  19. 8.4 Fresenius Kabi
  20. 8.4.1 Fresenius Kabi Company Information
  21. 8.4.2 Fresenius Kabi Business Overview
  22. 8.4.3 Fresenius Kabi Liposome Development and Manufacturing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fresenius Kabi Liposome Development and Manufacturing Service Product Portfolio
  24. 8.4.5 Fresenius Kabi Recent Developments
  25. 8.5 Fujifilm
  26. 8.5.1 Fujifilm Company Information
  27. 8.5.2 Fujifilm Business Overview
  28. 8.5.3 Fujifilm Liposome Development and Manufacturing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fujifilm Liposome Development and Manufacturing Service Product Portfolio
  30. 8.5.5 Fujifilm Recent Developments
  31. 8.6 GEA
  32. 8.6.1 GEA Company Information
  33. 8.6.2 GEA Business Overview
  34. 8.6.3 GEA Liposome Development and Manufacturing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GEA Liposome Development and Manufacturing Service Product Portfolio
  36. 8.6.5 GEA Recent Developments
  37. 8.7 Intertek
  38. 8.7.1 Intertek Company Information
  39. 8.7.2 Intertek Business Overview
  40. 8.7.3 Intertek Liposome Development and Manufacturing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Intertek Liposome Development and Manufacturing Service Product Portfolio
  42. 8.7.5 Intertek Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst